Interventional Cardiology Market: By Product Type (Coronary Stents, Catheters, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices And Others), By End Users (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Others), And Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Interventional Cardiology Market size was valued at USD 19,274.6 million in 2023 and is expected to grow at a 9.0% CAGR from 2024 to 2030. Interventional cardiology is a subspeciality in cardiology that uses specialized catheter-based techniques to diagnose and treat various heart diseases like congenital heart disease, coronary artery disease, vascular disease, and others. Interventional cardiology uses various imaging and diagnostic tools to diagnose cardiovascular functions such as blood flow, and blood pressure in major arteries in our body. The evolution of interventional cardiology techniques has eliminated traditional open-heart surgeries. The Rapid increase in the geriatric population, increasing awareness of cardiovascular drug disease and the increase in the consciousness of people to monitor cardiac health, rapid increase in chronic diseases like diabetes, and cardiac makers disease among the population is expected to drive the growth of interventional cardiology market in the forecasted years.

Furthermore, the increasing incidence of cardiovascular disease along with the growing healthcare expenditure in medical devices is expected to push the market growth in the forecasted years. In addition, the rise in tobacco consumption and the growing incidence of obesity is also expected to fuel the growth of the interventional cardiology market. Several government and non-government organizations including educational institutes and key market payers, have conducted public awareness campaigns to raise awareness regarding cardiac disease and its treatments. The advancement of technology and procedures in healthcare facilities like innovative cardiovascular devices and regulatory approvals are expected to fuel the growth of the interventional cardiology market in the forecasted years. However, the huge cost of interventional cardiac devices and the availability of alternative cardiac disease treatments are expected to hinder the growth of the interventional cardiology market in the forecasted years. 

Interventional Cardiology Market Key Developments:
  • In July 2021, Abbott launched its product XIENCE family of stents, which got USFDA’s approval for one month DAPT labeling for patients with high bleeding risk in US.

Interventional Cardiology Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Interventional Cardiology Market Dynamics

Interventional cardiology market is expected to grow due to the increasing prevalence cardiac diseases, the increase in number of geriatric patients across the globe. The increase in tobacco consumption and number of obesity population is expected to increase the demand and fuel the growth of interventional cardiology market. The increase in investments in research and development by market players and the launch of advanced products for better enhanced treatment and to launch new product portfolios are expected to boost the growth of interventional cardiology market. However, strict regulations for the manufacture of interventional cardiology devices and availability of effective first line treatment are expected to hinder the growth of interventional cardiology market in the forecasted years.

Key Features of the Reports

  • The interventional cardiology market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Interventional Cardiology Market Segmentation

By Product Type
  • Coronary Stents
  • Catheters
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
  • Endovascular Aneurysm Repair Stent Grafts
  • Inferior Vena Cava (IVC) Filters
  • Plaque Modification Devices
  • Hemodynamic Flow Alteration Devices
  • Others
By End Users
  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Frequently Asked Questions

Interventional Cardiology Market size was valued at USD 19,274.6 million in 2023 and is expected to grow at a 9.0% CAGR from 2024 to 2030

Increase in prevalence of cardiac disease and increased consumption of tobacco are expected to provide opportunity to the key market players in interventional cardiology market.

The leading players in the global Interventional Cardiology market are ABIOMED Inc., ACIST Medical Systems, B. Braun Melsungen AG, Biotronik SE & Co., Boston Scientific Corporation, Cardinal Health, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic, Merit Medical Systems, Koninklijke Philips N.V., Abbott, Terumo Corporation, Rontis Corporation Inc., Biosensors International Group Ltd.

Availability of alternative treatment and high cost of interventional cardiac devices are expected to restrain the growth of interventional cardiology market.

1.Executive Summary
2.Global Interventional Cardiology Market Introduction 
2.1.Global Interventional Cardiology Market  - Taxonomy
2.2.Global Interventional Cardiology Market  - Definitions
2.2.1.Product Type
2.2.2.End User
2.2.3.Region
3.Global Interventional Cardiology Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Interventional Cardiology Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Interventional Cardiology Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Coronary Stents
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Catheters
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Endovascular Aneurysm Repair Stent Grafts
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Inferior Vena Cava (IVC) Filters
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Plaque Modification Devices
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Hemodynamic Flow Alteration Devices
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Others
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
6.Global Interventional Cardiology Market  By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cardiac Catheterization Laboratories
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Ambulatory Surgical Centers
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Interventional Cardiology Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Interventional Cardiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Coronary Stents
8.1.2.Catheters
8.1.3.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
8.1.4.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
8.1.5.Endovascular Aneurysm Repair Stent Grafts
8.1.6.Inferior Vena Cava (IVC) Filters
8.1.7.Plaque Modification Devices
8.1.8.Hemodynamic Flow Alteration Devices
8.1.9.Others
8.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospitals
8.2.2.Cardiac Catheterization Laboratories
8.2.3.Ambulatory Surgical Centers
8.2.4.Others
8.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Interventional Cardiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Coronary Stents
9.1.2.Catheters
9.1.3.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
9.1.4.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
9.1.5.Endovascular Aneurysm Repair Stent Grafts
9.1.6.Inferior Vena Cava (IVC) Filters
9.1.7.Plaque Modification Devices
9.1.8.Hemodynamic Flow Alteration Devices
9.1.9.Others
9.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospitals
9.2.2.Cardiac Catheterization Laboratories
9.2.3.Ambulatory Surgical Centers
9.2.4.Others
9.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Interventional Cardiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Coronary Stents
10.1.2.Catheters
10.1.3.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
10.1.4.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
10.1.5.Endovascular Aneurysm Repair Stent Grafts
10.1.6.Inferior Vena Cava (IVC) Filters
10.1.7.Plaque Modification Devices
10.1.8.Hemodynamic Flow Alteration Devices
10.1.9.Others
10.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospitals
10.2.2.Cardiac Catheterization Laboratories
10.2.3.Ambulatory Surgical Centers
10.2.4.Others
10.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Interventional Cardiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Coronary Stents
11.1.2.Catheters
11.1.3.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
11.1.4.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
11.1.5.Endovascular Aneurysm Repair Stent Grafts
11.1.6.Inferior Vena Cava (IVC) Filters
11.1.7.Plaque Modification Devices
11.1.8.Hemodynamic Flow Alteration Devices
11.1.9.Others
11.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospitals
11.2.2.Cardiac Catheterization Laboratories
11.2.3.Ambulatory Surgical Centers
11.2.4.Others
11.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Interventional Cardiology Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Coronary Stents
12.1.2.Catheters
12.1.3.Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons
12.1.4.Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires
12.1.5.Endovascular Aneurysm Repair Stent Grafts
12.1.6.Inferior Vena Cava (IVC) Filters
12.1.7.Plaque Modification Devices
12.1.8.Hemodynamic Flow Alteration Devices
12.1.9.Others
12.2.  End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospitals
12.2.2.Cardiac Catheterization Laboratories
12.2.3.Ambulatory Surgical Centers
12.2.4.Others
12.3.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.ABIOMED Inc.
13.2.2.ACIST Medical Systems
13.2.3.B. Braun Melsungen AG
13.2.4.Biotronik SE & Co.
13.2.5.Boston Scientific Corporation
13.2.6.Cardinal Health
13.2.7.Edwards Lifesciences Corporation
13.2.8.Johnson & Johnson Services Inc.
13.2.9.Medtronic
13.2.10.Merit Medical Systems
13.2.11.Koninklijke Philips N.V.
13.2.12.Abbott
14. Research Methodology 
15. Appendix and Abbreviations 
  • ABIOMED Inc.
  • ACIST Medical Systems
  • B. Braun Melsungen AG
  • Biotronik SE & Co.
  • Boston Scientific Corporation
  • Cardinal Health
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic
  • Merit Medical Systems
  • Koninklijke Philips N.V.
  • Abbott
  • Terumo Corporation
  • Rontis Corporation Inc.
  • Biosensors International Group Ltd.

Adjacent Markets